Connect with us

Health

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial – DocWire News

Intensive Care Med. 2021 Nov 10. doi: 10.1007/s00134-021-06573-1. Online ahead of print.ABSTRACTPURPOSE: We compared dexamethasone…

Published

on

Article feature image

Intensive Care Med. 2021 Nov 10. doi: 10.1007/s00134-021-06573-1. Online ahead of print.
ABSTRACT
PURPOSE: We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending